Eli Lilly and Company (LLY)
USD 823.62
(3.72%)
USD 823.62
(3.72%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 10.32 Billion USD | 44.87% |
| 2022 | 7.12 Billion USD | 12.12% |
| 2021 | 6.35 Billion USD | 4.94% |
| 2020 | 6.05 Billion USD | 21.79% |
| 2019 | 4.97 Billion USD | -19.6% |
| 2018 | 6.18 Billion USD | 188.43% |
| 2017 | 2.14 Billion USD | -37.98% |
| 2016 | 3.45 Billion USD | 28.61% |
| 2015 | 2.68 Billion USD | 1.11% |
| 2014 | 2.65 Billion USD | -50.47% |
| 2013 | 5.37 Billion USD | 13.44% |
| 2012 | 4.73 Billion USD | -14.37% |
| 2011 | 5.52 Billion USD | -18.36% |
| 2010 | 6.77 Billion USD | 6.31% |
| 2009 | 6.37 Billion USD | 15.23% |
| 2008 | 5.52 Billion USD | 15.1% |
| 2007 | 4.8 Billion USD | 16.42% |
| 2006 | 4.12 Billion USD | 13.07% |
| 2005 | 3.64 Billion USD | -0.28% |
| 2004 | 3.65 Billion USD | 4.48% |
| 2003 | 3.5 Billion USD | 5.23% |
| 2002 | 3.32 Billion USD | -10.78% |
| 2001 | 3.72 Billion USD | 4.78% |
| 2000 | 3.55 Billion USD | 5.83% |
| 1999 | 3.36 Billion USD | 19.09% |
| 1998 | 2.82 Billion USD | 14.9% |
| 1997 | 2.45 Billion USD | 20.1% |
| 1996 | 2.04 Billion USD | 3.28% |
| 1995 | 1.98 Billion USD | 10.41% |
| 1994 | 1.79 Billion USD | 175.04% |
| 1993 | 652.6 Million USD | -43.52% |
| 1992 | 1.15 Billion USD | -34.65% |
| 1991 | 1.76 Billion USD | 14.87% |
| 1990 | 1.53 Billion USD | 32.16% |
| 1989 | 1.16 Billion USD | 11.27% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 4.43 Billion USD | 3.03% |
| 2024 Q2 | 4.3 Billion USD | 64.31% |
| 2024 Q1 | 2.61 Billion USD | -14.9% |
| 2023 Q1 | 1.49 Billion USD | -18.65% |
| 2023 Q2 | 2.12 Billion USD | 42.28% |
| 2023 FY | 10.32 Billion USD | 44.87% |
| 2023 Q3 | 450.4 Million USD | -78.81% |
| 2023 Q4 | 3.07 Billion USD | 583.41% |
| 2022 FY | 7.12 Billion USD | 12.12% |
| 2022 Q3 | 2.03 Billion USD | 17.78% |
| 2022 Q4 | 1.83 Billion USD | -9.95% |
| 2022 Q1 | 2.4 Billion USD | 25.41% |
| 2022 Q2 | 1.73 Billion USD | -27.99% |
| 2021 Q2 | 1.42 Billion USD | 23.64% |
| 2021 Q3 | 1.88 Billion USD | 31.7% |
| 2021 Q4 | 1.91 Billion USD | 1.91% |
| 2021 FY | 6.35 Billion USD | 4.94% |
| 2021 Q1 | 1.15 Billion USD | -42.01% |
| 2020 Q4 | 1.99 Billion USD | 55.84% |
| 2020 Q1 | 1.59 Billion USD | 13.61% |
| 2020 Q2 | 1.19 Billion USD | -24.77% |
| 2020 FY | 6.05 Billion USD | 21.79% |
| 2020 Q3 | 1.27 Billion USD | 6.81% |
| 2019 Q4 | 1.4 Billion USD | -2.13% |
| 2019 Q1 | 645.1 Million USD | -32.39% |
| 2019 Q2 | 1.49 Billion USD | 132.26% |
| 2019 FY | 4.97 Billion USD | -19.6% |
| 2019 Q3 | 1.43 Billion USD | -4.51% |
| 2018 FY | 6.18 Billion USD | 188.43% |
| 2018 Q2 | -33.2 Million USD | -102.29% |
| 2018 Q3 | 1.53 Billion USD | 4737.65% |
| 2018 Q1 | 1.45 Billion USD | 533.97% |
| 2018 Q4 | 954.2 Million USD | -38.03% |
| 2017 Q2 | 1.26 Billion USD | 2642.73% |
| 2017 Q4 | 229 Million USD | -62.18% |
| 2017 FY | 2.14 Billion USD | -37.98% |
| 2017 Q1 | 46.1 Million USD | -94.74% |
| 2017 Q3 | 605.5 Million USD | -52.11% |
| 2016 Q4 | 876.2 Million USD | -7.13% |
| 2016 Q2 | 923.3 Million USD | 28.99% |
| 2016 Q3 | 943.5 Million USD | 2.19% |
| 2016 FY | 3.45 Billion USD | 28.61% |
| 2016 Q1 | 715.8 Million USD | 78.99% |
| 2015 Q4 | 399.9 Million USD | -58.4% |
| 2015 FY | 2.68 Billion USD | 1.11% |
| 2015 Q1 | 525.2 Million USD | 39.53% |
| 2015 Q2 | 803 Million USD | 52.89% |
| 2015 Q3 | 961.3 Million USD | 19.71% |
| 2014 Q2 | 886.6 Million USD | 6.21% |
| 2014 FY | 2.65 Billion USD | -50.47% |
| 2014 Q1 | 834.8 Million USD | -7.33% |
| 2014 Q3 | 562 Million USD | -36.61% |
| 2014 Q4 | 376.4 Million USD | -33.02% |
| 2013 Q3 | 1.54 Billion USD | 2.77% |
| 2013 Q4 | 900.8 Million USD | -41.68% |
| 2013 FY | 5.37 Billion USD | 13.44% |
| 2013 Q1 | 1.42 Billion USD | 33.59% |
| 2013 Q2 | 1.5 Billion USD | 5.7% |
| 2012 Q2 | 1.2 Billion USD | -12.97% |
| 2012 Q4 | 1.06 Billion USD | -2.01% |
| 2012 Q3 | 1.08 Billion USD | -9.65% |
| 2012 Q1 | 1.38 Billion USD | 29.26% |
| 2012 FY | 4.73 Billion USD | -14.37% |
| 2011 Q1 | 1.28 Billion USD | -15.9% |
| 2011 Q3 | 1.58 Billion USD | -0.19% |
| 2011 Q4 | 1.06 Billion USD | -32.62% |
| 2011 Q2 | 1.58 Billion USD | 23.64% |
| 2011 FY | 5.52 Billion USD | -18.36% |
| 2010 FY | 6.77 Billion USD | 6.31% |
| 2010 Q3 | 1.75 Billion USD | -1.67% |
| 2010 Q4 | 1.52 Billion USD | -12.81% |
| 2010 Q1 | 1.7 Billion USD | 28.25% |
| 2010 Q2 | 1.78 Billion USD | 4.25% |
| 2009 Q4 | 1.33 Billion USD | -20.95% |
| 2009 Q2 | 1.49 Billion USD | -14.95% |
| 2009 Q3 | 1.68 Billion USD | 13.03% |
| 2009 Q1 | 1.75 Billion USD | 16.23% |
| 2009 FY | 6.37 Billion USD | 15.23% |
| 2008 Q1 | 1.26 Billion USD | 5.08% |
| 2008 Q3 | 1.45 Billion USD | 11.88% |
| 2008 Q2 | 1.29 Billion USD | 2.3% |
| 2008 Q4 | 1.5 Billion USD | 3.93% |
| 2008 FY | 5.52 Billion USD | 15.1% |
| 2007 Q4 | 1.2 Billion USD | -0.21% |
| 2007 FY | 4.8 Billion USD | 16.42% |
| 2007 Q1 | 1.13 Billion USD | 7.1% |
| 2007 Q2 | 1.25 Billion USD | 10.63% |
| 2007 Q3 | 1.2 Billion USD | -3.44% |
| 2006 FY | 4.12 Billion USD | 13.07% |
| 2006 Q4 | 1.05 Billion USD | 0.73% |
| 2006 Q3 | 1.04 Billion USD | 5.66% |
| 2006 Q2 | 993.6 Million USD | -3.02% |
| 2006 Q1 | 1.02 Billion USD | 4.39% |
| 2005 Q2 | 887.9 Million USD | 4.98% |
| 2005 Q3 | 933.5 Million USD | 5.14% |
| 2005 Q4 | 981.4 Million USD | 5.13% |
| 2005 FY | 3.64 Billion USD | -0.28% |
| 2005 Q1 | 845.8 Million USD | -13.24% |
| 2004 Q1 | 914.7 Million USD | 2.8% |
| 2004 Q3 | 863.6 Million USD | -4.63% |
| 2004 Q4 | 974.9 Million USD | 12.89% |
| 2004 FY | 3.65 Billion USD | 4.48% |
| 2004 Q2 | 905.5 Million USD | -1.01% |
| 2003 Q2 | 859.4 Million USD | 4.3% |
| 2003 Q1 | 824 Million USD | -7.7% |
| 2003 Q3 | 928.6 Million USD | 8.05% |
| 2003 Q4 | 889.8 Million USD | -4.18% |
| 2003 FY | 3.5 Billion USD | 5.23% |
| 2002 Q1 | 750.9 Million USD | -4.9% |
| 2002 Q4 | 892.7 Million USD | -0.2% |
| 2002 Q3 | 894.5 Million USD | 13.29% |
| 2002 FY | 3.32 Billion USD | -10.78% |
| 2002 Q2 | 789.6 Million USD | 5.15% |
| 2001 Q1 | 999 Million USD | 8.22% |
| 2001 Q4 | 789.6 Million USD | -11.63% |
| 2001 FY | 3.72 Billion USD | 4.78% |
| 2001 Q3 | 893.5 Million USD | -14.72% |
| 2001 Q2 | 1.04 Billion USD | 4.87% |
| 2000 Q3 | 1.01 Billion USD | 22.99% |
| 2000 Q1 | 795.6 Million USD | -17.94% |
| 2000 FY | 3.55 Billion USD | 5.83% |
| 2000 Q2 | 825.6 Million USD | 3.77% |
| 2000 Q4 | 923.1 Million USD | -9.09% |
| 1999 Q1 | 756.1 Million USD | 14.11% |
| 1999 Q3 | 897.7 Million USD | 21.25% |
| 1999 Q4 | 969.5 Million USD | 8.0% |
| 1999 FY | 3.36 Billion USD | 19.09% |
| 1999 Q2 | 740.4 Million USD | -2.08% |
| 1998 Q4 | 662.6 Million USD | -15.46% |
| 1998 Q3 | 783.8 Million USD | 22.13% |
| 1998 Q2 | 641.8 Million USD | -12.83% |
| 1998 Q1 | 736.3 Million USD | 15.17% |
| 1998 FY | 2.82 Billion USD | 14.9% |
| 1997 Q4 | 639.3 Million USD | -0.06% |
| 1997 Q1 | 638.8 Million USD | 18.41% |
| 1997 Q2 | 540.5 Million USD | -15.39% |
| 1997 Q3 | 639.7 Million USD | 18.35% |
| 1997 FY | 2.45 Billion USD | 20.1% |
| 1996 Q3 | 537.2 Million USD | 21.87% |
| 1996 Q4 | 539.5 Million USD | 0.43% |
| 1996 FY | 2.04 Billion USD | 3.28% |
| 1996 Q1 | 529.3 Million USD | 16.38% |
| 1996 Q2 | 440.8 Million USD | -16.72% |
| 1995 Q4 | 454.8 Million USD | -10.38% |
| 1995 FY | 1.98 Billion USD | 10.41% |
| 1995 Q3 | 507.5 Million USD | 10.66% |
| 1995 Q2 | 458.6 Million USD | -18.24% |
| 1995 Q1 | 560.9 Million USD | 101.4% |
| 1994 Q4 | 278.5 Million USD | -46.8% |
| 1994 Q1 | 517.8 Million USD | 171.37% |
| 1994 FY | 1.79 Billion USD | 175.04% |
| 1994 Q2 | 475.1 Million USD | -8.25% |
| 1994 Q3 | 523.5 Million USD | 10.19% |
| 1993 Q3 | 413.1 Million USD | -9.55% |
| 1993 Q2 | 456.7 Million USD | -10.15% |
| 1993 Q1 | 508.3 Million USD | 14.15% |
| 1993 FY | 652.6 Million USD | -43.52% |
| 1993 Q4 | -725.5 Million USD | -275.62% |
| 1992 Q1 | 580.1 Million USD | 33.91% |
| 1992 Q3 | -307.4 Million USD | -170.26% |
| 1992 Q2 | 437.5 Million USD | -24.58% |
| 1992 FY | 1.15 Billion USD | -34.65% |
| 1992 Q4 | 445.3 Million USD | 244.86% |
| 1991 FY | 1.76 Billion USD | 14.87% |
| 1991 Q3 | 409 Million USD | -4.95% |
| 1991 Q2 | 430.3 Million USD | -13.21% |
| 1991 Q4 | 433.2 Million USD | 5.92% |
| 1991 Q1 | 495.8 Million USD | 28.68% |
| 1990 FY | 1.53 Billion USD | 32.16% |
| 1990 Q2 | 357.6 Million USD | -16.86% |
| 1990 Q4 | 385.3 Million USD | 5.16% |
| 1990 Q1 | 430.1 Million USD | 103.55% |
| 1990 Q3 | 366.4 Million USD | 2.46% |
| 1989 FY | 1.16 Billion USD | 11.27% |
| 1989 Q1 | 1.22 Billion USD | 161.85% |
| 1989 Q3 | 251.2 Million USD | -16.54% |
| 1989 Q2 | 301 Million USD | -75.43% |
| 1989 Q4 | 211.3 Million USD | -15.88% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbbVie Inc. | 12.75 Billion USD | 19.061% |
| Bristol-Myers Squibb Company | 16.59 Billion USD | 37.791% |
| Bristol-Myers Squibb Company Ce | 16.59 Billion USD | 37.791% |
| Johnson & Johnson | 23.4 Billion USD | 55.891% |
| Merck & Co., Inc. | 2.95 Billion USD | -249.54% |
| Novartis AG | 9.76 Billion USD | -5.696% |
| Organon & Co. | 1.32 Billion USD | -676.93% |
| Pfizer Inc. | 3.35 Billion USD | -207.395% |